Previous close | 136.70 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | N/A |
Market cap | N/A |
Beta (5Y monthly) | 1.24 |
PE ratio (TTM) | 0.69 |
EPS (TTM) | 2.07 |
Earnings date | 05 Aug 2024 - 09 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
NEW YORK, May 06, 2024--IFF (NYSE: IFF) today announced that Glenn Richter, IFF’s Chief Financial and Business Transformation Officer, plans to retire Dec. 31, 2024 after a three-year tenure with the company. A succession process has been initiated to evaluate internal and external candidates to succeed Richter as CFO.
NEW YORK, May 06, 2024--IFF (NYSE: IFF) reported financial results for the first quarter ended March 31, 2024.
IFF, a global leader in food and beverage, home and personal care and health, will introduce its full suite of plant-based and cellulosic-derived solutions for dietary supplements and over-the-counter (OTC) drugs at Vitafoods Europe 2024. This is the first time IFF Pharma Solutions will showcase its full clean-label portfolio for oral dosage forms at Vitafoods Europe, May 14-16, Geneva, Switzerland, booth E90.